| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Apr―16 |
Construction and immunogenicity analysis of a recombinant baculovirus targeting the N protein of SARS-CoV-2 |
Bohan Yu, Xiaoli Mo, Li Sui, Yujia Fang, Xudong Tang, Ping Qian |
| 2 |
[GO] |
2025―Mrz―06 |
Multiplicity of infection and culture medium on the SARS-CoV-2 virus like-particles production by baculovirus/insect system |
Luis Giovani de Oliveira Guardalini, Felipe Moura Dias, Samanta Omae Camalhonte, Jaci Leme, Thaissa Consoni Bernardino, Felipe Soares Sposito, et al. (+5) Eduardo Dias, Renato Mancini Astray, Aldo Tonso, Soraia Attie Calil Jorge, Eutimio Gustavo Fernández Núñez |
| 3 |
[GO] |
2024―Aug―25 |
Amyloidogenesis of SARS-CoV-2 delta plus and omicron variants receptor-binding domain (RBD): impact of SUMO fusion tag |
Sadegh Zargan, Hasan Jalili, Bahareh Dabirmanesh, Saba Mesdaghinia, Khosro Khajeh |
| 4 |
[GO] |
2024―Jul―27 |
Plant production of recombinant antigens containing the receptor binding domain (RBD) of two SARS-CoV-2 variants |
Flavia Fagiani, Rachele Frigerio, Anna Maria Salzano, Andrea Scaloni, Carla Marusic, Marcello Donini |
| 5 |
[GO] |
2023―Mai―06 |
Multi-pathogen based chimeric vaccine to fight against COVID-19 and concomitant coinfections |
Rupal Ojha, Satyendra Singh, Nidhi Gupta, Ketan Kumar, Aditya K. Padhi, Vijay Kumar Prajapati |
| 6 |
[GO] |
2023―Mrz―13 |
Inactivation of SARS-CoV-2 variants by nitrogen-doped titanium dioxide loaded with metals as visible-light photocatalysts |
Takashi Matsuyama, Shu Saeki, Satoru Kosaka, Yoriko Matsuoka, Yoshifumi Aoki, Yasushi Itoh, Takao Imaeda |
| 7 |
[GO] |
2023―Jan―28 |
Enzymatic approaches against SARS-CoV-2 infection with an emphasis on the telomere-associated enzymes |
Alireza Valdiani, Hamideh Ofoghi |
| 8 |
[GO] |
2022―Nov―01 |
A gold nanoparticles-based lateral flow assay utilizing baculovirus expressed recombinant nucleocapsid and receptor binding domain proteins for serodetection of IgG and IgM against SARS-CoV-2 |
Reda Salem, Amany M. Elshamy, Noha Kamel, Soha Younes, Ohoud M. Marie, Fatma R. Waly, et al. (+2) Alaa A. El-Kholy, Wael Elmenofy |
| 9 |
[GO] |
2022―Sep―26 |
High-yield production in Escherichia coli and convenient purification of a candidate vaccine against SARS-CoV-2 |
Giulia Maltoni, Lorenzo Scutteri, Francesca Mensitieri, Fabrizio Dal Piaz, Alejandro Hochkoeppler |
| 10 |
[GO] |
2022―Mai―24 |
A novel property of hexokinase inhibition by Favipiravir and proposed advantages over Molnupiravir and 2 Deoxy d glucose in treating COVID-19 |
Prajakta Kulkarni, Sriram Padmanabhan |
| 11 |
[GO] |
2022―Jan―19 |
Stem cells or their exosomes: which is preferred in COVID-19 treatment? |
Nashmin Fayazi Hosseini, Razieh Dalirfardouei, Mohammad Reza Aliramaei, Rezvan Najafi |
| 12 |
[GO] |
2022―Jan―17 |
Detection of homologous recombination events in SARS-CoV-2 |
Azadeh Lohrasbi-Nejad |
| 13 |
[GO] |
2021―Nov―27 |
Plant-derived VLP: a worthy platform to produce vaccine against SARS-CoV-2 |
Farshad Hemmati, Mohsen Hemmati-Dinarvand, Marziye Karimzade, Daria Rutkowska, Mohammad Hadi Eskandari, Sayyad Khanizadeh, Alireza Afsharifar |
